Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):127-32. Epub 2008 Feb 8

Current guidelines on management of HIV-infected pregnant women: impact on mode of delivery.

Abstract

OBJECTIVE:

To evaluate acceptance, feasibility and difficulties in the application of a policy of vaginal delivery in selected cases in HIV-infected women.

STUDY DESIGN:

HIV-infected women delivering March 2002 to December 2004 and enrolled in a prospective observational study in a University hospital tertiary care center were included. A vaginal delivery was not considered if labor before 36 weeks of pregnancy, preterm premature rupture of membranes, on non-highly active antiretroviral therapy (HAART) or viral load >1000copies/mL. Main outcome measures were mode of delivery, prematurity, acceptance of vaginal delivery and mother-to-child transmission of HIV infection.

RESULTS:

The study included 91 pregnancies, with a total of 95 fetuses. Eighty percent (n=73) of women knew their HIV infection status before becoming pregnant and 57 (63%) were on HAART at conception. Median gestational age at delivery was 37 weeks (range 22-41). Twelve women delivered a live-born before 36 weeks, all with a caesarean section. Among 74 women who reached 36 weeks gestation, 47 (64%) met the pre-established criteria for vaginal delivery, of whom 21 (45%) delivered vaginally. The most common reason for not having a vaginal delivery was the woman’s request for a caesarean section. No cases of HIV vertical transmission occurred (0/90, 95% CI 0-4.02%).

CONCLUSION:

Recommending vaginal delivery among HIV-infected women in selected cases was well accepted, particularly once the policy became established. Nevertheless, a high proportion of HIV-infected women will continue to require caesarean section delivery.

Share this:

Year: 2008

Journal: European Journal of Obstetrics Gynecology Reproductive Biology

PMID: 18262324